if you want an alternative, name the living driver

Your consultant’s slide deck already has an alternatives sleeve. Private equity, hedge funds, real assets, private credit, infrastructure, natural capital — the labels are familiar. The harder question is not whether something belongs on that slide. It is whether the thing you add changes what your book is exposed to, or only changes how long you wait to find out.

Meadows, reefs, forests, and watersheds exist whether or not anyone files them under alternatives. Ensurance funds their condition. It is not an alt sleeve — and we are not an alternatives GP packaging a new fund. Holdable claims on living systems exist when the payoff is contracted — a certificate, a coin, or a structure partners execute. This post is education, not investment advice; volumes on live instruments are still small, and you should run your own diligence.

the allocator’s real question

Consultants and data providers (CAIA, Preqin, and the usual allocator surveys) describe alternative investments as anything outside public equity, traditional bonds, and cash. That definition is useful for reporting. It is not a portfolio property.

When a family office or endowment asks how to choose an alternative investment, they are usually asking one of three things:

Those are different jobs. A category label does not tell you which job a name fulfills. That is why diligence belongs in tests, not in taxonomy. For the full checklist, use five tests for an alternative that actually diversifies. This close names what to identify before you score.

Embedded objection, stated plainly: "We already have real assets." Timber, farmland, and core-plus property are legitimate sleeves. Biological growth can be a different engine — the five-tests card scores working nature as mixed, not automatic. Rates, cap rates, operating leverage, and appraisal smoothing still sit on many of those books. Filing them under alternatives does not finish the test. The same objection applies to "we already have private credit" when the borrower pool is correlated with the same corporate balance sheets you could reach through public high yield. The shelf did its job; your book still needs a named cause if you wanted a cause.

what is an alternative investment — and what it is not

An alternative investment is a distribution category: access to illiquid or complex strategies, often with capital calls, gates, and layered fees. Private equity alternative investments still price off corporate earnings and leverage cycles. Income-oriented alternative income investments still depend on a tenant, borrower, or royalty counterparty. Alternative asset funds wrap an underlying exposure in liquidity promises the wrapper may not be able to keep.

The useful half of the sleeve is real. Illiquidity can be a feature when managers are not forced to mark daily. Complexity can be rewarded when underwriting is genuinely different. None of that removes the need to name the engine.

If you want an alternative that earns a place in the book, name:

1. The living driver — what physical or biological process must stay intact for the thesis to work (water storage, pollination, fire regime, coastal buffer, soil function).
2. The contracted payor — who pays you, under what obligation, and whether that payment is senior to equity stories when stress arrives.
3. The wrapper — fund, interval vehicle, coin, certificate, or direct claim — and whether wrapper risk can erase the asset story (see the asset can diversify you. the fund can still fail).

Skip the slide until those three have plain-language answers.

a worked contrast (flood storage, not fund branding)

Imagine two memo lines on the same IC agenda.

Memo A: "Add 3% to alternatives via a diversified real assets fund with quarterly liquidity." The driver sentence is vague. The payor is the fund’s NAV. In a redemption event, the driver becomes who else wants out.

Memo B: "Fund flood storage and channel maintenance upstream of three municipal systems we already insure or serve." The living driver is watershed function. The payor is whoever writes the check — a utility, municipality, insurer, or other counterparty — because avoided loss, a tariff, a resilience charge, or a performance payment showed up in their budget. Avoided loss is the reason they pay, not the payor. Each structure has different legal and portfolio math. The hold might be a certificate on a place-based agent, exposure through a coin that routes proceeds, or a direct agreement your counsel structures. None of those choices are interchangeable; each is a wrapper decision you make after the driver and payor are credible.

Memo A is easy to approve because it looks like peers. Memo B is harder because it forces specificity. Portfolio construction rewards the second kind of difficulty when the first kind only added fees and a gate.

private markets, income alts, and wrappers — one line each

This series opened on definition, then walked the usual alt corridors:

• what an alternative investment actually is — the shelf map.
• private markets are still a market — lockups do not change an earnings driver.
• income alts still need a payor — coupons are someone else’s check.
• the asset can diversify you. the fund can still fail — Hipgnosis-style wrapper lessons (a royalty vehicle can fail while the songs still play) apply to any open-end story.

The spine is the same in every post: category ≠ cause. Most alts are another ticker with friction. A living system is a candidate driver only when the payoff is contracted and the hold matches the claim.

when nature belongs in the alternatives conversation

Nature shows up on allocator slides under real assets or natural capital. That filing is honest as taxonomy. It is not automatic permission to treat a watershed like a timber IRR.

What makes nature an alternative investment in the portfolio sense is not the word "natural." It is whether the return or protection you care about traces to a living system whose condition you can fund, measure, and tie to a payor — insurer, utility, municipality, or supply-chain counterparty — rather than to a single equity beta. Protocol proceeds can route that payment; they are not a substitute for naming who benefits enough to pay.

Working nature with a contracted beneficiary can be scored on the same five-tests card when you separate protection (loss avoided) from yield (cash distributed). It is not an automatic pass. Pure ecological outcomes without a payor are a different job — philanthropy, public finance, or an explicit impact sleeve — not a diversifier merely because the deck says alternatives.

Ensurance sits at the hold layer: specific ensurance (certificates) tied to agents and places, general ensurance (coins) as protocol-wide currency, and pools where the mechanism routes proceeds. We facilitate structures partners execute; we do not present ourselves as your next private markets commitment letter.

how to choose — without letting the shelf choose for you

Use five tests for an alternative that actually diversifies as the diligence list. This close only adds the sentence you should be able to write before you score:

This position makes money or avoids loss because _____ stays functional. Fill the blank with a living process — water storage, pollination, fire regime, coastal buffer, soil function — not "manager skill," "multiple expansion," or "the alts sleeve." If you cannot name the process, you are not ready for the card.

Then name the entity whose budget line still funds you in a bad year, and only then pick the hold. If the answer is "exit to another fund," you have liquidity risk wearing an alt label. If the vehicle’s liquidity is shorter than the living system’s recovery, you already know the wrapper failure from the asset can diversify you. the fund can still fail.

If hedge, diversifier, income, and inflation are doing double duty in your IPS, get the words straight first: a hedge against what? and the fine print of the free lunch.

If nature survives that pre-filter and the five tests, size it like any immature sleeve: evidence first, liquidity second, story last.

what we will not claim

We will not tell you that buying any ensurance instrument automatically diversifies a 60/40 book. Correlation is earned, not marketed — that case lives in the different-engine posts, not here. We will not quote industry AUM we cannot open in a source. We will not name-drop a branded alt news feed or pretend we run a private equity fund with a nature theme. Partners execute legal and land work; we coordinate protocol rails and accounting logic that make condition legible to capital. If your policy requires a GP with a ten-year track record in closed-end funds, say so upfront — we may be the wrong door, and that is a useful outcome.

frequently asked questions

how do you choose an alternative investment?

Start with the job (diversify, earn income, hedge a named loss, or meet a policy sleeve), then name the driver and payor before you compare fund brands. Run the position through five tests for an alternative that actually diversifies. Reject names that only add lockup and fees to exposures you already own in public form.

what makes nature an alternative investment?

Nature is filed as an alternative when consultants put it under real assets or natural capital. That filing is taxonomy. Portfolio relevance requires a living driver and a contracted payor (or explicit protection value) that does not collapse into equity beta — plus a hold and wrapper that survive stress. Without that chain, nature is a values allocation, not an alt in the portfolio-construction sense.

what should you ask before allocating to alternatives?

Ask for the driver sentence, the payor’s stress behavior, how correlation was measured, what the wrapper does in a redemption shock, and which regime breaks the thesis. Ask whether the team is a GP selling access or a protocol layer funding condition on a place you can point to on a map. Ask for legal docs, not deck adjectives. Ask how additionality is defined — whether your capital changes management on the ground or only buys a secondary claim on someone else’s story. Ask what happens if the biological target slips a season: is your payment deferred, adjusted, or purely mark-to-model?

taking action

If you are deciding whether a living-system hold belongs in the alternatives sleeve — hedge, diversifier, income, or protection — we can walk the role question with you. This is not a pitch for a blind pool.

• Talk through the portfolio role
• Solutions for investors
• Specific ensurance — certificates tied to place
• Five tests — diligence checklist

Nothing here is an offer or recommendation. Live instruments exist; scale is early. Bring your IPS, your policy band, and your skepticism.

the series

1. what an alternative investment actually is
2. private markets are still a market
3. income alts still need a payor
4. the asset can diversify you. the fund can still fail
5. if you want an alternative, name the living driver